Cited by 398Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsPain Management and Opioid Use

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials

Open access

Lynch, Mary E., Campbell, Fiona·2011·British Journal of Clinical Pharmacology

DOI 10.1111/j.1365-2125.2011.03970.xPMC PMC3243008

Open this paper in CoChat — free account Open PDF

Abstract

Effective therapeutic options for patients living with chronic pain are limited. The pain relieving effect of cannabinoids remains unclear. A systematic review of randomized controlled trials (RCTs) examining cannabinoids in the treatment of chronic non‐cancer pain was conducted according to the PRISMA statement update on the QUORUM guidelines for reporting systematic reviews that evaluate health care interventions. Cannabinoids studied included smoked cannabis, oromucosal extracts of cannabis based medicine, nabilone, dronabinol and a novel THC analogue. Chronic non‐cancer pain conditions included neuropathic pain, fibromyalgia, rheumatoid arthritis, and mixed chronic pain. Overall the quality of trials was excellent. Fifteen of the eighteen trials that met the inclusion criteria demonstrated a significant analgesic effect of cannabinoid as compared with placebo and several reported significant improvements in sleep. There were no serious adverse effects. Adverse effects most commonly reported were generally well tolerated, mild to moderate in severity and led to withdrawal from the studies in only a few cases. Overall there is evidence that cannabinoids are safe and modestly effective in neuropathic pain with preliminary evidence of efficacy in fibromyalgia and rheumatoid arthritis. The context of the need for additional treatments for chronic pain is reviewed. Further large studies of longer duration examining specific cannabinoids in homogeneous populations are required. Linked Article This article is linked to a themed issue in the British Journal of Pharmacology on Respiratory Pharmacology. To view this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue‐1

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2011.03970.x

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity With Depression-Anxiety Disorders
Tsang, A., Von Korff, M., Lee, S., Alonso, J., Karam, E., Angermeyer, M. C., Borges, G. L. G., Bromet, E. J., de Girolamo, G., de Graaf, R., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.05.005 · Cited by 1,157
Chronic pain in Australia: a prevalence study.
Blyth, F. M., March, L. M., Brnabic, A. J. M., Jorm, L. R., Williamson, M., & Cousins, M. J. (2001) · Pain · doi:10.1016/s0304-3959(00)00355-9 · Cited by 1,096
Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Prevalence of undertreatment in cancer pain. A review of published literature
Deandrea, S., Montanari, M., Moja, L., & Apolone, G. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn419 · Cited by 871
Universities and tobacco money
Cohen, J. E. (2001) · British medical journal · doi:10.1136/bmj.323.7303.1 · Cited by 870
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827

Show all 62 references

Research works printed but not linked: 2

10.1001/jama.290.13.1757 · DOI · Paper page
10.1016/j.neuropharm.2005.02.010 · DOI · Paper page

Sorted by citations

Items 201–300 of 398

Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids
Mayar, S., Memarpoor‐Yazdi, M., Makky, A., Sarokhalil, R. E., & D’Avanzo, N. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.848540 · Cited by 13
Should oncologists trust cannabinoids?
Creangă-Murariu, I., Filipiuc, L.-E., Cuciureanu, M. D., Tamba, B.-I., & Alexa‐Stratulat, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1211506 · Cited by 13
Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality
Carrascosa, A. J., Navarrete, F., Saldaña, R., García‐Gutiérrez, M. S., Moreno, B. M., Navarro, D., Gómez-Guijarro, F. M., Gasparyan, A., Murcia-Sánchez, E., Torregrosa, A. B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116268 · Cited by 16
Medical Cannabis for the Treatment of Inflammation
Namdar, D., & Koltai, H. (2018) · Natural Product Communications · doi:10.1177/1934578x1801300304 · Cited by 13
Efficacy of cannabinoids in fibromyalgia: a literature review
Anaya, H. J. M., Ortiz, M. P. T., Valencia, D. H. F., & Ribero, O. F. G. (2021) · Colombian Journal of Anesthesiology · doi:10.5554/22562087.e980 · Cited by 16
Cannabinoids in the management of chronic pain: a front line clinical perspective
Lynch, M. E. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0059 · Cited by 13
Self-citation
Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey
Mezaache, S., Donadille, C., Martin, V., Gadelius, M. L. B., Appel, L., Spire, B., Madrid, L. B., Bastien, M., & Roux, P. (2022) · Harm Reduction Journal · doi:10.1186/s12954-022-00611-x · Cited by 13
Inverse electron demand Diels-Alder reaction in total synthesis of bioactive natural products
Rashid, S., Lone, W. I., Rashid, A., & Bhat, B. A. (2024) · Tetrahedron Chem · doi:10.1016/j.tchem.2024.100066 · Cited by 12
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
O’Brien, K., Beilby, J., Frans, M., Lynskey, M. T., Barnes, M., Jayasuriya, M., Athanasiou‐Fragkouli, A., Blair, P., & Nutt, D. J. (2023) · Drug Science Policy and Law · doi:10.1177/20503245231172535 · Cited by 14
Physicians as gatekeepers in the use of medical marijuana.
Thompson, J. W., & Koenen, M. A. (2011) · PubMed · Cited by 13
Cannabis som medisin
Bramness, J. G. (2015) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.14.1426 · Cited by 11
Meta-analysis of medical cannabis outcomes and associations with cancer
Castle, R., Marzolf, J. R., Morris, M., & Bushell, W. C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1490621 · Cited by 11
A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework
Erridge, S., Miller, M., Gall, T., Costanzo, A., Pacchetti, B., & Sodergren, M. H. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0020 · Cited by 11
Antinociceptive effects of JWH015 in female and male rats
Craft, R. M., Greene, N. Z., & Wakley, A. A. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000337 · Cited by 11
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Temiscamingue region of Quebec
St-Amant, H., Ware, M. A., Julien, N., & Lacasse, A. (2015) · CMAJ Open · doi:10.9778/cmajo.20140095 · Cited by 10
Themed issue on cannabinoids in biology and medicine
Bab, I. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01536.x · Cited by 10
Role of Cannabinoids in Pain Management
Halawa, O. I., Furnish, T. J., & Wallace, M. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00056-5 · Cited by 10
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Fu, R. F., Morasco, B. J., Kansagara, D. L., & Chou, R. (2021) · doi:10.23970/ahrqepccer250 · Cited by 10
Cannabinoids and chronic pelvic pain in women: Focus on endometriosis
Marcu, I., Gee, A. D., & Lynn, B. (2021) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265211011277 · Cited by 10
Medical use of cannabis: an addiction medicine perspective
Cook, J., Lloyd‐Jones, D. M., Ogden, E., & Bonomo, Y. A. (2015) · Internal Medicine Journal · doi:10.1111/imj.12761 · Cited by 10
Why Insurance Companies Should Pay for Medical Cannabis
Casarett, D., & Abrams, D. I. (2019) · The American Journal of Bioethics · doi:10.1080/15265161.2019.1567193 · Cited by 11
Cannabinoids in neuropathic pain treatment: pharmacological insights and clinical outcomes from recent trials
Khan, M. G., Hussain, S. H. A., Alkhayl, F. F. A., Ahsan, M., & Ridha‐Salman, H. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04134-7 · Cited by 10
Enantioselective Total Synthesis of Potent 9β-11-Hydroxyhexahydrocannabinol
Maurya, V., & Appayee, C. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b02962 · Cited by 9
Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats
Jergová, S., Perez, C., Imperial, J. S., Gajavelli, S., Jain, A., Abin, A., Olivera, B. M., & Sagen, J. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173182 · Cited by 9
Medicinal cannabis: Time to lighten up?
Juurlink, D. N. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.140309 · Cited by 9
The use of cannabinoids in chronic pain
Reynolds, T. D., & Osborn, H. L. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-010417 · Cited by 9
Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review
Al-Husinat, L., Obeidat, S., Azzam, S., Al-Gwairy, Y., Obeidat, F., Sharie, S. A., Haddad, D., Haddad, F. F., Rekatsina, M., Leoni, M. L. G., et al. (2025) · Clinics and Practice · doi:10.3390/clinpract15010016 · Cited by 9
FIRST STEPS: THE EARLY YEARS OF THE IASP 1973–1984. Louisa E. Jones.IASP Press, Seattle, Washington, 2010, softbound, 50 pages.
Lipman, A. G. (2010) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2010.529988 · Cited by 8
Cannabinoid Hyperemesis Syndrome
Bhatt, S., & Queen, J. R. (2019) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-019-00178-1 · Cited by 8
Fibromyalgia and Chronic Fatigue Syndrome: Management Issues
Bourke, J. H. (2015) · Advances in psychosomatic medicine · doi:10.1159/000369087 · Cited by 8
Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management
Taverner, T. (2015) · International Journal of Palliative Nursing · doi:10.12968/ijpn.2015.21.8.380 · Cited by 8
Are Cannabis, Cannabis-Derived Products, and Synthetic Cannabinoids a Therapeutic Tool for Rheumatoid Arthritis? A Friendly Summary of the Body of Evidence
Schulze-Schiappacasse, C., Durán, J., Bravo-Jeria, R., Verdugo‐Paiva, F., Morel-Marambio, M., & Rada, G. (2021) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001745 · Cited by 9
The use of cannabis for management of chronic pain
Bostwick, J. M. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.08.004 · Cited by 8
Examining the use of cannabidiol and delta‐9‐tetrahydrocannabinol‐based medicine among individuals diagnosed with dementia living within residential aged care facilities: Results of a double‐blind randomised crossover trial
Timler, A., Bulsara, C., Bulsara, M. K., Vickery, A. W., Jacques, A., & Codde, J. (2023) · Australian Journal on Ageing · doi:10.1111/ajag.13224 · Cited by 7
The Associations of Neighborhood Availability of Marijuana Dispensaries and DATA-2000 Waivered Providers with Hospital Stays Related to Opioids
Liang, D., & Shi, Y. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1650775 · Cited by 7
Evidence for the use of cannabis-based medicines in osteoarthritis: a scoping review
Xiao, A. T. Y., Turk, T., Deol, K., Zhang, S., Aref, H. A. T., Campbell, A., Jones, C. A., Yamamoto, S. S., Dennett, L., Kolewaski, L., et al. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07001-7 · Cited by 8
Traitements de la douleur en rhumatologie
Vergne‐Salle, P., Beaulieu, P., Coutaux, A., Sichère, P., Perrot, S., & Bertin, P. (2014) · Cited by 7
Automated gathering and analysis of cannabinoids treatment data
Chugh, R., Chawla, N., Gracias, R. M., Padda, J. S., Li, S., Nguyen, M. T., Spichkova, M., & Mantri, N. L. (2019) · Procedia Computer Science · doi:10.1016/j.procs.2019.09.432 · Cited by 7
Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?
Vannabouathong, C., Zhu, M. T., Chang, Y., & Bhandari, M. (2021) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/11795441211002492 · Cited by 7
Synthesis of (−)‐Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)‐Catalyzed Cycloisomerization
Carreras, J., Kirillova, M. S., & Echavarren, A. M. (2016) · Angewandte Chemie · doi:10.1002/ange.201601834 · Cited by 7
Online pharmacies: buyer beware
Kelly, B. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.067 · Cited by 7
Drugs for neuropathic pain
Rastogi, S., & Campbell, F. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199642656.003.0048 · Cited by 7
Self-citation
Erratum zu: Verträglichkeit und Sicherheit von Cannabinoiden bei neuropathischen Schmerzsyndromen. Eine systematische Übersichtsarbeit von randomisierten, kontrollierten Studien
Petzke, F. W., Enax‐Krumova, E., & Häuser, W. (2017) · Der Schmerz · doi:10.1007/s00482-017-0242-x · Cited by 7
Chronic Non-cancer Pain
Mayo, P., & Walter, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-11775-7_21 · Cited by 7
Assessment of hemp oil–based cannabidiol use in a community-based pharmacy setting
Gicewicz, E., Gatewood, S. B. S., Kaefer, T. N., Nadpara, P. A., & Goode, J. R. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.02.012 · Cited by 6
Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids?
Anand, R., Painuli, R., Kumar, V., & Singh, P. P. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116164 · Cited by 6
Should doctors be allowed to prescribe cannabinoids for pain in Australia and New Zealand?
Shipton, E. A., & Shipton, E. E. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413520048 · Cited by 6
High-normal blood pressure and impaired renal function. A prospective study in a population-based cohort.
Bo, S., Gruden, G., Charbonnier, E., Martorana, M., Gambino, R., Cassader, M., Gentile, L., Cavallo‐Perin, P., & Durazzo, M. (2014) · PubMed · Cited by 6
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review
Mohiuddin, M. M., Mizubuti, G. B., Haroutounian, S., Smith, S. M., Campbell, F. A., Park, R., & Gilron, I. (2018) · JMIR Research Protocols · doi:10.2196/11637 · Cited by 6
Self-citation
The Role of Endocannabinoid System in Neuroprotection: Molecular Targets and Therapeutic Opportunities
Thapa, S., & Singh, S. K. (2023) · Integrative Medicine Reports · doi:10.1089/imr.2022.0091 · Cited by 4
Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review
Lopera, V., Restrepo, J., & Amariles, P. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100524 · Cited by 8
Medical Marijuana for Failed Back Surgical Syndrome: A Viable Option for Pain Control or an Uncontrolled Narcotic?
Aggarwal, S. K., Pangarkar, S. S., Carter, G. T., Tribuzio, B. A., Miedema, M. L., & Kennedy, D. J. “. J. ”. (2014) · PM&R · doi:10.1016/j.pmrj.2014.03.006 · Cited by 5
Tıbbi Esrar Psikiyatrik Bozuklukların Tedavisinde Kullanılabilir mi?
Tellioğlu, T., & Tellioğlu, Z. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120223123828 · Cited by 5
Medical Marijuana Policy Reform Reaches Florida: A Scoping Review.
Howell, K., Washington, A., Williams, P. M., Mathis, A., & Luque, J. S. (2019) · PubMed · Cited by 5
STUDY ON THE LEVEL OF KNOWLEDGE ABOUT MEDICAL MARIJUANA AMONG MEDICAL STUDENTS
Bielski, A., Hus, A., Sadowska, A., & Kosson, D. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202004105 · Cited by 5
Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis
Sobotka, L. A., Mumtaz, K., Hinton, A. M., Kelly, S. G., Conteh, L. F., Michaels, A. J., Hanje, A. J., & Wellner, M. R. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.10.008 · Cited by 5
Orthopedic Patients Are Highly Amenable to Cannabis-Based Products for the Treatment of Musculoskeletal Pain
Karakash, W. J., Bolia, I. K., Levian, B. A., Chu, T. N., Kim, D. R., Fathi, A., Liu, J. N., Petrigliano, F. A., & Weber, A. E. (2025) · Orthopedics · doi:10.3928/01477447-20250114-02 · Cited by 4
Cannabinoids versus placebo or no intervention for pain: protocol for a systematic review with meta-analysis and trial sequential analysis
Barakji, J. A., Korang, S. K., Feinberg, J. B., Maagaard, M., Gluud, C. N., Mathiesen, O., & Jakobsen, J. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031574 · Cited by 6
The Medical Use of Marijuana: Issues and Indications
Horowitz, S. (2014) · Alternative and Complementary Therapies · doi:10.1089/act.2014.20601 · Cited by 4
Cannabinoids for Pain in Dementia: The Good, the Bad, and the Ugly
Ahmed, A. I. A., van den Elsen, G. A. H., van der Marck, M. A., & Rikkert, M. G. M. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12817 · Cited by 4
Fibromyalgia
Crofford, L. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00052-8 · Cited by 4
Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?
Moser, U. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-243072 · Cited by 20
Comparison of the Two Common Solvents for THC and CBD Extractions
Wongwailikhit, K., & Jiratchaya, J. (2021) · Proceedings of the World Congress on Mechanical, Chemical, and Material Engineering · doi:10.11159/iccpe21.115 · Cited by 4
Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
Sun, N., Cunha, N., Amar, S., & Brown, S. (2022) · Canadian Journal of Pain · doi:10.1080/24740527.2022.2132138 · Cited by 4
Rough-set based learning: Assessing patterns and predictability of anxiety, depression, and sleep scores associated with the use of cannabinoid-based medicine during COVID-19
Ramanna, S., Ashrafi, N., Loster, E., Debroni, K., & Turner, S. (2023) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2023.981953 · Cited by 4
Fibromyalgia and Centralized Pain States
Brummett, C. M., & Clauw, D. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00026-7 · Cited by 4
Consideraciones en cuanto al uso medicinal y recreacional de la marihuana y sus efectos sobre el pulmón
T, G. A. (2015) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482015000300004 · Cited by 5
Are cannabinoids an effective treatment for chronic non-cancer pain?
Allende-Salazar, R. F., & Gabriel Rada, G. (2017) · Medwave · doi:10.5867/medwave.2017.6972 · Cited by 4
General Innovations in Pain Management
Deng, A. J., Patel, M., Eigner, C., Moghim, R., & Abd-Elsayed, A. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14175957 · Cited by 3
Marijuana and Prescription Pain Reliever Use among Cigarette Smokers
Goldberg, R. L., & Cataldo, J. K. (2018) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2018.1506598 · Cited by 3
Dorsal Root Entry Zone Lesioning: Systematic Review
Galafassi, G. Z., de Aguiar, P. H. P., Takahashi, A. A. R., & Pagura, J. R. (2020) · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery · doi:10.1055/s-0040-1719003 · Cited by 3
Evidencia científica actualizada del tratamiento con cannabis medicinal en pacientes con dolor crónico
Henares, J. F. G., & Moraga, J. D. S. (2022) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2022.4024/2022 · Cited by 3
Cannabinoids
Lalsare, S. S. (2022) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.4103/ajprhc.ajprhc_9_21 · Cited by 3
Principes de prise en charge d'une douleur chronique
Guillemet, G., & Guy-Coichard, C. (2016) · Time to knit · doi:10.1016/s1283-0887(15)65784-x · Cited by 3
Cannabinoids for the Treatment of Chronic Pain: A Critical Review of Randomized Controlled Trials
Hassan, S. I. (2018) · Journal of Pain Management & Medicine · doi:10.35248/2684-1320.18.4.131 · Cited by 4
Cannabis en el tratamiento del dolor crónico no oncológico
Evelyn Muñoz, S. (2015) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2015.71526 · Cited by 3
The Efficacy and Safety of Use of Cannabis and Cannabinoid Products for Pain Relief in Orthopaedic Conditions and Trauma
Shah, D., Murhekar, S., Ward, M., Sagane, S., & Pahwani, A. (2025) · Cureus · doi:10.7759/cureus.87208 · Cited by 2
From farm to bedside: Potential of medical cannabis in global health
Tendwa, M. B., Appidi, T., Chitsunge, B., Moreau, M., Okole, B., Kalombo, L., Mallum, A. A., Ngoma, T. A., Weadock, D. P., Tanifum, E. A., et al. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103205 · Cited by 2
Interactions between cannabis use and chronic pain on sleep architecture: Findings from in-home EEG recordings
Brown, T., & Filbey, F. M. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00785 · Cited by 2
Review of Opioid Prescribing in the Osteopathic and Ambulatory Setting
Hussein, A. I., Bekampis, C. F., & Jermyn, R. T. (2019) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2019.134 · Cited by 2
The therapeutic use of cannabis in South Africa: panacea or scourge?
Maule, W. J. (2022) · Journal of Medical Laboratory Science & Technology of South Africa · doi:10.36303/jmlstsa.2022.4.1.93 · Cited by 2
Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential
Walczyńska-Dragon, K., Fiegler-Rudol, J., Nitecka-Buchta, A., & Baron, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124186 · Cited by 5
Emerging concepts and treatment in neuropathic pain
Kulkantrakorn, K. (2012) · Cited by 2
Principios de tratamiento del dolor crónico
Guillemet, G., & Guy-Coichard, C. (2016) · EMC - Kinesiterapia - Medicina Física · doi:10.1016/s1293-2965(16)78902-x · Cited by 2
Cannabinoids and Their Effects on Painful Neuropathy
Selvarajah, D., Gandhi, R. A., & Tesfaye, S. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00109-5 · Cited by 3
Wirkt Cannabis bei neurologischen oder psychiatrischen Indikationen?
Freund, W., Laub, L., & Preuss, U. W. (2017) · NeuroTransmitter · doi:10.1007/s15016-017-6155-1 · Cited by 2
Bipolar disorders and comorbid conditions – Ethical considerations in sports
Kaufman, K. R., Campeas, M., Coluccio, M., Babalola, R., & Tobia, A. (2017) · Apunts Sports Medicine · doi:10.1016/j.apunts.2017.10.001 · Cited by 2
New synthetic cannabinoids are coming to the drug scene
Patočka, J., & Kuča, K. (2012) · Kontakt · doi:10.32725/kont.2012.039 · Cited by 2
Stakeholders’ Views on Barriers to Research on Controlled Substances
Rhodes, E., Andreae, M. H., Bourgiose, T., Indyk, D., Rhodes, R., & Sacks, H. S. (2016) · The Journal of Clinical Ethics · doi:10.1086/jce2016274308 · Cited by 2
Pain specialist management of sexual pain–IV. Pharmacological
Vogel, J. J. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeac012 · Cited by 2
Cannabis Use in Fibromyalgia
Farré, M., Farré, A., Fiz, J., & Torrens, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00112-5 · Cited by 2
Canabinoides na dor crónica: uma revisão baseada na evidência
de Família, M., Silva, R. G., Remtula, S. P., de Família, M., Gonçalves, T. C., & de Família, M. (2021) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v37i2.12784 · Cited by 1
Perceptions in Orthopedic Surgery on the Use of Cannabis in Treating Pain: A Survey of Musculoskeletal Trauma Patients—Results From the Canadian POSIT Study
Gjorgjievski, M., Madden, K., Bullen, C., Koziarz, F., Koziarz, A., Cenic, A., Li, S., Bhandari, M., & Johal, H. S. (2024) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002848 · Cited by 1
Opioid Use Following Primary Unilateral Total Knee Arthroplasty Varies With Age
Fahad, S., Bryman, J. A., Behun, M. A., Salimi, M., Vyge, O., Rosen, N., Miner, T. M., & Jennings, J. M. (2025) · Arthroplasty Today · doi:10.1016/j.artd.2025.101714 · Cited by 1
Medication-overuse headache: Bridging therapies for detoxification
Wakerley, B. R., & Koonalintip, P. (2025) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2025.109205 · Cited by 1
Cannabis-intoxicated patients with small burns require more opioid analgesics in the acute hospitalization period
Wang, S., Emeh, A., Stanton, E. W., Manasyan, A., Choe, D., Gasho, J. O., Wong, S., Boudiab, E. M., Johnson, M. B., Yenikomshian, H. A., et al. (2025) · Burns · doi:10.1016/j.burns.2025.107758 · Cited by 1
CB1R and GlyT2 interaction in spinal glycinergic circuits drives neuropathic mechanical pain
Wang, Q., Jiang, Z., Huang, C., Zhang, X., Zhao, J., Ma, H., Qi, J., Li, J., Yang, Y., He, X., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.11.016 · Cited by 2
Association of Combined Marijuana and Opioid Use with Major Depressive Disorder Among Adults with Chronic Conditions in the United States
Graham, T. A., Wiener, R. C., Mitra, S., Wang, H., Shen, C., Pedaprolu, L., & Sambamoorthi, U. (2026) · Substance Use Research and Treatment · doi:10.1177/29768357261423812 · Cited by 1
Alternative splicing fuels the functional diversity of GPCR in neurological and psychiatric disorders: An emerging path toward RNA-targeted neurotherapeutics
Wang, E., Kang, Y., Chen, D., Tian, R., Hu, Y., Wang, H., Liu, J., Zhou, Z., Tian, T., Xu, H., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118026 · Cited by 1
Long-Term Inhaled Cannabis Therapy for Chronic Low Back Pain: A Five-Year Retrospective Analysis of Prospectively Collected Patient-Reported Outcomes in 241 Treatment-Refractory Patients
Robinson, D., Khatib, M., Lavon, E., Kafri, N., Rashed, W. A., Murad, H., & Yassin, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061255 · Cited by 1

Authors: Lynch, M. E., & Campbell, F.
Affiliations: Dalhousie University (CA)
University of Toronto (CA)
Corresponding author: Lynch, Mary E.
ORCID: Lynch, Mary E.
Campbell, Fiona
Venue: British Journal of Clinical Pharmacology
Publisher: Wiley
Published: 2011-10-11
Volume: 72
Issue: 5
Pages: 735-744
ISSN: 0306-5251 (ISSN-L)
1365-2125
DOI: 10.1111/j.1365-2125.2011.03970.x
PMC: PMC3243008
OpenAlex: W1589884020
Cited by: 397
References: 62
Citations by year: 2026: 17 · 2025: 20 · 2024: 13 · 2023: 19 · 2022: 21 · 2021: 23 · 2020: 25 · 2019: 25 · 2018: 36 · 2017: 28 · 2016: 39 · 2015: 51 · 2014: 35 · 2013: 16 · 2012: 24
FWCI: 3.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Clinical Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: cannabinoids, chronic non-cancer pain, neuropathic pain, fibromyalgia, rheumatoid arthritis, cannabis smoking, nabilone, dronabinol, analgesic effect, sleep improvement, adverse effects, tolerability
MeSH terms: Cannabinoids, Humans, Neuralgia, Randomized Controlled Trials as Topic, Analgesics, Non-Narcotic, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks